Exploration of the impact of neuronal dysfunction through examination of myelination biomarkers-dimethyl acetyls, essential fatty acids, renegrade lipids via red cell lipid biopsy and blood chemistry biomarkers with definitive evidence-based biomedical intervention towards metabolic stability of lipid metabolism, replenishing phospholipids, reversal of the demyelination process and re-modeling of the brain architecture.